SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Expansion Plans 8-K Filing 2024 - Research Agreement Shuttle Pharmaceuticals entered a research agreement with UCSF for a prostate cancer project, costing $291,607, and has exclusive rights to related intellectual property.Get access to all SEC 8-K filings of the SHUTTLE PHARMACEUTICALS HOLDINGS INC